Will NCT06693895 (GlaxoSmithKline) still show a study completion date of 23 November 2026 or earlier when checked on 23 December 2026?
deadline 2026-12-23
confidence medium
tier 4 evidence
30%PolySignal estimate
Resolution criterion
Yes if, when NCT06693895 is read on clinicaltrials.gov on 23 December 2026, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 23 November 2026 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 6 October 2026: NCT06693895 is registered as RECRUITING, sponsored by GlaxoSmithKline, with 750 participants. Started 2024-11; announced primary completion 2026-11-23, announced study completion 2026-11-23. Record last updated 2026-05-29. The date under test is 2026-11-23. Source: clinicaltrials.gov/study/NCT06693895
What pushes it up
- GlaxoSmithKline is a major pharmaceutical sponsor with substantial resources to keep clinical trial timelines on track [1].
What pushes it down
- The trial has a large cohort of 750 participants and was still in the recruiting phase as of May 2026, leaving a very tight window to finish all follow-ups by November 2026 [1].
- Clinical trials of this scale frequently experience enrollment or operational delays, which typically lead to timeline extensions [2].
- The registry has not been updated since May 2026, meaning any delays incurred during the latter half of 2026 have not yet been reported but are highly likely to be updated by December 2026 [1].
What would move this number most
Whether recruitment was completed ahead of schedule or if GSK will update the registry with an extended timeline before the December 2026 check date.
How this number is built
| Deadline | 2026-12-23 |
| Base rate | 35% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 28 · 32 (spread 4 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-06 07:41 |
| Model | gemini-3.5-flash |